JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB41934

Anti-Retinoic Acid Receptor alpha 抗体 [H1920]

Anti-Retinoic Acid Receptor alpha antibody [H1920]

4

(2 Reviews)

|

(21 Publications)

Mouse Monoclonal Retinoic Acid Receptor alpha antibody. Suitable for Flow Cyt and reacts with Human samples. Cited in 21 publications. Immunogen corresponding to Recombinant Fragment Protein within Human RARA aa 1-50.

別名を表示する

NR1B1, RARA, Retinoic acid receptor alpha, RAR-alpha, Nuclear receptor subfamily 1 group B member 1

1 Images
Flow Cytometry - Anti-Retinoic Acid Receptor alpha antibody [H1920] (AB41934)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Retinoic Acid Receptor alpha antibody [H1920] (AB41934)

Overlay histogram showing MCF7 cells stained with ab41934 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab41934, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed.

This image was generated using the ascites version of the product.

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

H1920

アイソタイプ

IgG1

キャリアフリー

No

交差種

Human

アプリケーション

Flow Cyt

applications

免疫原

Recombinant Fragment Protein within Human RARA aa 1-50. The exact immunogen used to generate this antibody is proprietary information.

P10276

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "" }, "Dog": { "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "" } } }

製品の詳細

This product was changed from ascites to tissue culture supernatant on 3rd April 2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

出荷温度及び保存条件

製品の状態
Liquid
精製度
Tissue culture supernatant
バッファー組成
pH: 7 Preservative: 0.1% Sodium azide
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Retinoic Acid Receptor alpha (RARA) a member of the nuclear receptor superfamily functions as a transcription factor activated by retinoic acid. Commonly referenced in literature RARA has an approximate molecular mass of 50 kDa. It is expressed in a variety of tissues including the liver the lung and the immune system. By forming heterodimers with retinoid X receptors RARA regulates the transcription of genes linked to cell differentiation proliferation and apoptosis.
Biological function summary

RARA plays an essential role in mediating the effects of retinoic acid in the body. It is part of a larger receptor complex that interacts with co-regulators to modulate gene expression. This process is significant for embryonic development and the maintenance of normal physiological functions. Through its action RARA contributes to the proper development of organs and is critical for maintaining immune homeostasis and enabling the cellular response to environmental changes.

Pathways

RARA's activity impacts important signaling routes such as the retinoic acid signaling pathway and the Wnt signaling pathway. It collaborates with proteins like retinoid X receptors (RXRs) and other nuclear receptors to influence gene expression processes. These pathways maintain cellular differentiation and tissue homeostasis demonstrating RARA's integrative role in cellular signaling and communication.

RARA's dysregulation has been linked to acute promyelocytic leukemia (APL) and some autoimmune diseases. In APL aberrant fusion proteins involving RARA disrupt normal transcriptional regulation leading to malignant transformation. Additionally the interaction of RARA with proteins such as promyelocytic leukemia protein (PML) further influences the disease's development. Research on these associations highlights the therapeutic potential of targeting RARA activities for disease intervention and treatment strategies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Receptor for retinoic acid (PubMed : 16417524, PubMed : 19850744, PubMed : 20215566, PubMed : 21152046, PubMed : 37478846). Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes (PubMed : 21152046, PubMed : 28167758, PubMed : 37478846). The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5 (PubMed : 19398580, PubMed : 28167758). In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone deacetylation, chromatin condensation and transcriptional suppression (PubMed : 16417524). On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation (PubMed : 19850744, PubMed : 20215566, PubMed : 37478846, PubMed : 9267036). Formation of a complex with histone deacetylases might lead to inhibition of RARE DNA element binding and to transcriptional repression (PubMed : 28167758). Transcriptional activation and RARE DNA element binding might be supported by the transcription factor KLF2 (PubMed : 28167758). RARA plays an essential role in the regulation of retinoic acid-induced germ cell development during spermatogenesis (By similarity). Has a role in the survival of early spermatocytes at the beginning prophase of meiosis (By similarity). In Sertoli cells, may promote the survival and development of early meiotic prophase spermatocytes (By similarity). In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). Together with RXRA, positively regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1 signaling response to pulsatile shear stress in vascular endothelial cells (PubMed : 28167758). In association with HDAC3, HDAC5 and HDAC7 corepressors, plays a role in the repression of microRNA-10a and thereby promotes the inflammatory response (PubMed : 28167758).
See full target information RARA

文献 (21)

Recent publications for all applications. Explore the full list and refine your search

Nucleic acids research 53: PubMed40167329

2025

Genomic regions occupied by both RARα and VDR are involved in the convergence and cooperation of retinoid and vitamin D signaling pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Hamidreza Mianesaz,Loránd Göczi,Gergely Nagy,Szilárd Póliska,Lina Fadel,Dóra Bojcsuk,András Penyige,Krisztina Szirák,Farah AlHaman,László Nagy,György Vámosi,Lajos Széles

eLife 12: PubMed39792435

2025

Surprising features of nuclear receptor interaction networks revealed by live-cell single-molecule imaging.

Applications

Unspecified application

Species

Unspecified reactive species

Liza Dahal,Thomas G W Graham,Gina M Dailey,Alec Heckert,Robert Tjian,Xavier Darzacq

Nucleic acids research 52:4-21 PubMed37993417

2023

Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF.

Applications

Unspecified application

Species

Unspecified reactive species

Katerina Cermakova,Ling Tao,Milan Dejmek,Michal Sala,Matthew D Montierth,Yuen San Chan,Ivanshi Patel,Courtney Chambers,Mario Loeza Cabrera,Dane Hoffman,Ronald J Parchem,Wenyi Wang,Radim Nencka,Eveline Barbieri,H Courtney Hodges

International journal of molecular sciences 21: PubMed32916897

2020

Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All- Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines.

Applications

Unspecified application

Species

Unspecified reactive species

Silvia Paukovcekova,Dalibor Valik,Jaroslav Sterba,Renata Veselska

Theranostics 10:9686-9701 PubMed32863954

2020

Retinoic acid promotes metabolic maturation of human Embryonic Stem Cell-derived Cardiomyocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Shumei Miao,Dandan Zhao,Xiaoxiao Wang,Xuan Ni,Xing Fang,Miao Yu,Lingqun Ye,Jingsi Yang,Hongchun Wu,Xinglong Han,Lina Qu,Lei Li,Feng Lan,Zhenya Shen,Wei Lei,Zhen-Ao Zhao,Shijun Hu

Theranostics 10:6839-6853 PubMed32550907

2020

Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.

Applications

Unspecified application

Species

Unspecified reactive species

Gengyi Zou,Xiaotong Zhang,Lun Wang,Xiyang Li,Tianyu Xie,Jin Zhao,Jie Yan,Longlong Wang,Haoyu Ye,Shunchang Jiao,Rong Xiang,Yi Shi

Journal of neuroinflammation 16:175 PubMed31472680

2019

All trans-retinoic acid protects against acute ischemic stroke by modulating neutrophil functions through STAT1 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Cai,Julie Wang,Mengyan Hu,Xiao Chen,Zhengqi Lu,Joseph A Bellanti,Song Guo Zheng

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33:7037-7048 PubMed30870006

2019

Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.

Applications

Unspecified application

Species

Unspecified reactive species

Jun-Jie Lei,Hui-Qing Li,Zhi-Huai Mo,Ke-Jia Liu,Ling-Juan Zhu,Chun-Yi Li,Wen-Li Chen,Lei Zhang

Nature communications 10:120 PubMed30631056

2019

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target.

Applications

Unspecified application

Species

Unspecified reactive species

Shuofeng Yuan,Hin Chu,Jasper Fuk-Woo Chan,Zi-Wei Ye,Lei Wen,Bingpeng Yan,Pok-Man Lai,Kah-Meng Tee,Jingjing Huang,Dongdong Chen,Cun Li,Xiaoyu Zhao,Dong Yang,Man Chun Chiu,Cyril Yip,Vincent Kwok-Man Poon,Chris Chung-Sing Chan,Kong-Hung Sze,Jie Zhou,Ivy Hau-Yee Chan,Kin-Hang Kok,Kelvin Kai-Wang To,Richard Yi-Tsun Kao,Johnson Yiu-Nam Lau,Dong-Yan Jin,Stanley Perlman,Kwok-Yung Yuen

Cancer cell 34:596-610.e11 PubMed30300581

2018

Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting.

Applications

Unspecified application

Species

Unspecified reactive species

Antonia Rotolo,Valentina S Caputo,Monika Holubova,Nicoleta Baxan,Olivier Dubois,Mohammed Suhail Chaudhry,Xiaolin Xiao,Katerina Goudevenou,David S Pitcher,Kyriaki Petevi,Carolina Kachramanoglou,Sandra Iles,Kikkeri Naresh,John Maher,Anastasios Karadimitris
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com